DK258479A - Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden - Google Patents

Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden

Info

Publication number
DK258479A
DK258479A DK258479A DK258479A DK258479A DK 258479 A DK258479 A DK 258479A DK 258479 A DK258479 A DK 258479A DK 258479 A DK258479 A DK 258479A DK 258479 A DK258479 A DK 258479A
Authority
DK
Denmark
Prior art keywords
procedure
oxazold
indians
spiro
intermediates
Prior art date
Application number
DK258479A
Other languages
Danish (da)
English (en)
Inventor
R C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK258479A publication Critical patent/DK258479A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Moulding By Coating Moulds (AREA)
  • Dental Preparations (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK258479A 1978-08-21 1979-06-20 Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden DK258479A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (1)

Publication Number Publication Date
DK258479A true DK258479A (da) 1980-02-22

Family

ID=25466700

Family Applications (1)

Application Number Title Priority Date Filing Date
DK258479A DK258479A (da) 1978-08-21 1979-06-20 Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden

Country Status (34)

Country Link
US (1) US4200642A (de)
JP (4) JPS6011914B2 (de)
AR (1) AR225614A1 (de)
AT (1) AT366689B (de)
AU (1) AU535170B2 (de)
BE (1) BE878311A (de)
CA (1) CA1121361A (de)
CH (1) CH639974A5 (de)
CS (1) CS208129B2 (de)
DD (1) DD146602A5 (de)
DE (2) DE2933441C2 (de)
DK (1) DK258479A (de)
EG (1) EG14639A (de)
ES (1) ES483511A1 (de)
FI (1) FI65255C (de)
FR (3) FR2442851A1 (de)
GB (2) GB2028318B (de)
GR (1) GR71913B (de)
HU (1) HU179746B (de)
IE (1) IE48932B1 (de)
IL (1) IL58076A (de)
IN (1) IN152416B (de)
IT (1) IT1123536B (de)
LU (1) LU81613A1 (de)
NL (1) NL7906318A (de)
NO (1) NO792699L (de)
NZ (1) NZ191350A (de)
PH (1) PH18091A (de)
PL (1) PL130686B1 (de)
PT (1) PT70086A (de)
SE (1) SE447116B (de)
SU (1) SU942597A3 (de)
YU (1) YU41488B (de)
ZA (1) ZA794379B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
SG56656G (en) * 1980-07-28 1987-03-27 Pfizer Hypoglycemic 5-substituted oxazolidine-2, 4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES8400116A1 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―３―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
HU206618B (en) * 1986-01-17 1992-12-28 Pfizer Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
US6399640B1 (en) 1999-06-18 2002-06-04 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
DE60032898T2 (de) 1999-06-18 2007-10-25 Merck & Co., Inc. Arylthiazolidindion- und aryloxazolidinderivate
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
RU2020123382A (ru) 2017-12-21 2022-01-21 Эссити Хайджин Энд Хелт Актиеболаг Впитывающее изделие и способ изготовления впитывающего изделия
BR112020008382A2 (pt) 2017-12-21 2020-11-03 Essity Hygiene And Health Aktiebolag artigo absorvente com vedações de canal e método para a fabricação do artigo absorvente

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
FR2440950A1 (fr) 1980-06-06
JPS55129279A (en) 1980-10-06
YU199979A (en) 1983-06-30
US4200642A (en) 1980-04-29
JPS55129288A (en) 1980-10-06
CH639974A5 (fr) 1983-12-15
JPS5528996A (en) 1980-02-29
BE878311A (fr) 1980-02-20
JPS55129280A (en) 1980-10-06
IT1123536B (it) 1986-04-30
FI792567A (fi) 1980-02-22
FR2442851A1 (fr) 1980-06-27
FI65255B (fi) 1983-12-30
SE7906949L (sv) 1980-02-22
FR2440949A1 (fr) 1980-06-06
FR2442851B1 (de) 1983-06-17
ES483511A1 (es) 1980-09-01
SE447116B (sv) 1986-10-27
JPS5946517B2 (ja) 1984-11-13
GR71913B (de) 1983-08-16
EG14639A (en) 1985-03-31
ATA560579A (de) 1981-09-15
AU535170B2 (en) 1984-03-08
ZA794379B (en) 1980-08-27
CS208129B2 (en) 1981-08-31
JPS6011914B2 (ja) 1985-03-28
CA1121361A (en) 1982-04-06
DE2933441A1 (de) 1980-02-28
FR2440950B1 (de) 1981-06-12
DD146602A5 (de) 1981-02-18
JPS5943954B2 (ja) 1984-10-25
NO792699L (no) 1980-02-22
FI65255C (fi) 1984-04-10
AT366689B (de) 1982-04-26
JPS6011915B2 (ja) 1985-03-28
DE2953954C2 (de) 1987-12-03
AR225614A1 (es) 1982-04-15
IL58076A0 (en) 1979-12-30
IT7925182A0 (it) 1979-08-20
NZ191350A (en) 1984-04-27
IN152416B (de) 1984-01-07
GB2033904B (en) 1982-08-04
GB2028318A (en) 1980-03-05
PT70086A (en) 1979-09-01
DE2953954A1 (de) 1982-09-02
IE791592L (en) 1980-02-21
GB2033904A (en) 1980-05-29
YU41488B (en) 1987-08-31
HU179746B (en) 1982-12-28
GB2028318B (en) 1982-08-04
PL217881A1 (de) 1981-01-02
NL7906318A (nl) 1980-02-25
PL130686B1 (en) 1984-08-31
PH18091A (en) 1985-03-20
SU942597A3 (ru) 1982-07-07
IE48932B1 (en) 1985-06-26
DE2933441C2 (de) 1987-04-23
LU81613A1 (fr) 1980-04-21
AU5009279A (en) 1980-02-28
FR2440949B1 (de) 1981-06-12
IL58076A (en) 1982-07-30

Similar Documents

Publication Publication Date Title
DK258479A (da) Spiro-oxazoldindioner fremgangsmaade til deres fremstilling samt deres anvendelse og mellemprodukter til udoevelse af fremgangsmaaden
DK86079A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK325079A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK365079A (da) Fremgangsmaade til fremstilling af 1-alfa-hydroxylerede calciferoler
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK3880A (da) Fremgangsmaade til fremstilling af peptidylargininaldehydderivater og disses anvendelse
DK68179A (da) Fremgangsmaade til fremstilling af 9-aminodibenzoepyraner
DK377080A (da) Vandige dispersioner af ren harpiks
DK132779A (da) Fremgangsmaade til fremstilling af cishexahydrodibenzoepyranoner og tetrahydrobenzoxoiner
DK115979A (da) Heterocycliske forbindelser deres fremstilling og deres anvendelse til fremstilling af azopigmenter samt disse azopigmenters anvendelse
DK18179A (da) 2-pyrrolidon-forbindelser og fremgangsmaade til deres fremstilling samt deres anvendelse til fremstilling af farmakologisk aktive forbindelser
DK268579A (da) Fremgangsmaade til fremstilling af phenetamolaminer
DK77479A (da) Fremgangsmaade til fremstilling af penicilliner
DK307279A (da) Fremgangsmaade til fremstilling af phenolethere
DK113079A (da) Fremgangsmaade til fremstilling af n-oxacyclylalkyl-piperidyl-diazaforbindelser og anvendelsen deraf
DK265779A (da) Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK69479A (da) Fremgangsmaade til fremstilling af 2-phenylimino-imidazolidiner
DK433779A (da) Fremgangsmaade til fremstilling af phenylquinolizidiner
DK184579A (da) Estere af substituerede 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepiner,fremgangsmaade til deres fremstilling samt deres anvendelse
DK461179A (da) Fremgangsmaade til fremstilling af azolylketaler og deres anvendelse som mikrobicider
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK543079A (da) Fremgangsmaade til fremstilling af benzaldehyder
DK267779A (da) Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
DK20578A (da) Fremgangsmaade til femstilling af aliphatisk substituerede 4-(phenyl)-1-aza-cyloalkaner samt anvendelse deraf

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment